E7-23759. Designation of Oripavine as a Basic Class of Controlled Substance; Correction  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration (DEA), Justice.

    ACTION:

    Final rule; correcting amendments.

    SUMMARY:

    On September 24, 2007, the Drug Enforcement Administration (DEA) published in the Federal Register a final rule (72 FR 54208) designating oripavine (3-O-demethylthebaine or 6,7,8,14-tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol) as a basic class in schedule II of the Controlled Substances Act (CSA). The drug code for oripavine was inadvertently designated as 9335, a drug code which is already used to identify a schedule I controlled substance. This correction corrects that error and assigns a different drug code to oripavine.

    DATES:

    Effective December 10, 2007.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Christine A. Sannerud, PhD, Chief, Drug and Chemical Evaluation Section, Drug Enforcement Administration, Washington, DC 20537, by e-mail, ode@dea.usdoj.gov or by fax, (202) 353-1263.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    On September 24, 2007, the Drug Enforcement Administration (DEA) published a Final Rule in the Federal Register (72 FR 54208) designating oripavine (3- O-demethylthebaine or 6,7,8,14-tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methylmorphinan-3-ol) as a basic class in schedule II of the Controlled Substances Act (CSA). In the final rule, the drug code for oripavine was inadvertently listed as 9335. This is the drug code for the schedule I controlled substance, drotebanol. Upon publication of this rule, the drug code for oripavine will be amended to 9330.

    Start Amendment Part

    Accordingly, 21 CFR part 1308 is corrected by making the following correcting amendments:

    End Amendment Part Start Part

    PART 1308—SCHEDULES OF CONTROLLED SUBSTANCES

    End Part Start Amendment Part

    1. The authority citation for part 1308 continues to read as follows:

    End Amendment Part Start Authority

    Authority: 21 U.S.C. 811, 812, 871(b), unless otherwise noted.

    End Authority Start Amendment Part

    2. Section 1308.12(b)(1) is amended by revising the entry (xii) to read as follows:

    End Amendment Part
    Schedule II.
    * * * * *

    (b) * * *

    (1) * * *

    * * * * *
    (xii) Oripavine9330
    * * * * *
    Start Signature

    Dated: November 26, 2007.

    Joseph T. Rannazzisi,

    Deputy Assistant Administrator, Office of Diversion Control.

    End Signature End Supplemental Information

    [FR Doc. E7-23759 Filed 12-7-07; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Effective Date:
12/10/2007
Published:
12/10/2007
Department:
Drug Enforcement Administration
Entry Type:
Rule
Action:
Final rule; correcting amendments.
Document Number:
E7-23759
Dates:
Effective December 10, 2007.
Pages:
69618-69618 (1 pages)
Docket Numbers:
Docket No. DEA-309F
PDF File:
e7-23759.pdf